Kaviaar schreef op 9 februari 2021 18:01:
[...]
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 54 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Phase II, Double-blind, Placebo-controlled, Randomized, Cross-over, Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema Due to C1-inhibitor Deficiency Type I and II
Actual Study Start Date : February 3, 2021
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : September 2022
Recruitment Status :
RecruitingFirst Posted : November 5, 2020
Last Update Posted : February 9, 2021
Het is maar een onderzoek(je) DM.
54 personen...